- Tytuł:
- Phase II trial of sequential gefitinib after minor response or partial response to chemotherapy in Chinese patients with advanced non-small-cell lung cancer.
- Autorzy:
- Źródło:
- BMC cancer [BMC Cancer] 2006 Dec 16; Vol. 6, pp. 288. Date of Electronic Publication: 2006 Dec 16.
- Typ publikacji:
- Clinical Trial, Phase II; Journal Article
- MeSH Terms:
-
Antineoplastic Agents/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*drug therapy
Lung Neoplasms/*drug therapyQuinazolines /*therapeutic use
Adenocarcinoma/drug therapy ; Adenocarcinoma/pathology ; Adult ; Antineoplastic Agents/toxicity ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; China ; Disease Progression ; Female ; Gefitinib ; Humans ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Male ; Neoplasm Staging ; Patient Selection ;Quinazolines /toxicity ; Survival Analysis
Czasopismo naukowe